Referenced in: none

Automatically associated channels: TRP , TRPM , TRPM3

Title: Pregnenolone sulphate-independent inhibition of TRPM3 channels by progesterone.

Authors: Yasser Majeed, Sarka Tumova, Ben L Green, Victoria A L Seymour, Daniel M Woods, Anil K Agarwal, Jacqueline Naylor, Shannon Jiang, Helen M Picton, Karen E Porter, David J O'Regan, Katsuhiko Muraki, Colin W G Fishwick, David J Beech

Journal, date & volume: Cell Calcium, 2012 Jan , 51, 1-11

PubMed link: http://www.ncbi.nlm.nih.gov/pubmed/22000496

Abstract
Transient Receptor Potential Melastatin 3 (TRPM3) is a widely expressed calcium-permeable non-selective cation channel that is stimulated by high concentrations of nifedipine or by physiological steroids that include pregnenolone sulphate. Here we sought to identify steroids that inhibit TRPM3. Channel activity was studied using calcium-measurement and patch-clamp techniques. Progesterone (0.01-10μM) suppressed TRPM3 activity evoked by pregnenolone sulphate. Progesterone metabolites and 17β-oestradiol were also inhibitory but the effects were relatively small. Dihydrotestosterone was an inhibitor at concentrations higher than 1μM. Corticosteroids lacked effect. Overlay assays indicated that pregnenolone sulphate, progesterone and dihydrotestosterone bound to TRPM3. In contrast to dihydrotestosterone, progesterone inhibited nifedipine-evoked TRPM3 activity or activity in the absence of an exogenous activator, suggesting a pregnenolone sulphate-independent mechanism of action. Dihydrotestosterone, like a non-steroid look-alike compound, acted as a competitive antagonist at the pregnenolone sulphate binding site. Progesterone inhibited endogenous TRPM3 in vascular smooth muscle cells. Relevance of TRPM3 or the progesterone effect to ovarian cells, which have been suggested to express TRPM3, was not identified. The data further define a chemical framework for competition with pregnenolone sulphate at TRPM3 and expand knowledge of steroid interactions with TRPM3, suggesting direct steroid binding and pregnenolone sulphate-independent inhibition by progesterone.